QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For…
| Price | $10.60 |
|---|---|
| Market cap | $722.78M |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| Exchange | NASDAQ |
| 52-week range | 9.92-35.58 |
| Beta | 0.68 |
Explore QDEL's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.